UK Government to Begin Giving HPV Vaccine to Boys Amid Public Outcry

by Christina England
Health Impact News
The UK government has recently announced that, by September 2019, boys aged 12 to 13 years will be given the human papillomavirus (HPV) vaccine, a vaccine that has been available to girls in the UK for the past ten years.
The decision was made because the vaccine, originally offered to girls in the UK to protect them against HPV, a virus believed to cause cervical cancer, is now believed to be able to protect individuals from oral, throat, penile and anal cancers, as well.
On July 24, 2018, the BBC News reported that:

HPV is the name given to a large group of viruses, which can be caught through any kind of sexual contact with another person who already has it.
Doctors say most HPV infections go away by themselves, but sometimes infections can lead to a variety of serious problems.
For boys, this includes cancer of the anus, penis, mouth and throat.

A further report on the UK’s decision, published by FiercePharma, stated that:

Based on a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI), the U.K. government announced on Tuesday that the vaccine will be offered to boys aged 12 and 13 in an effort to protect them against several types of cancer caused by the virus.
The vaccine has been offered to girls for a decade under the program, and critics have urged the government to offer the vaccine to boys as well. When the government initially decided against expanding the program, it said immunizations in girls would provide “herd protection” for boys. The JCVI has been reviewing vaccinations in boys since 2013.

They continued:

On Tuesday, one of the groups pushing immunization for boys, HPV Action, said it’s “delighted” with the move. According to the group, the decision brings the U.K. in line with 20 other countries that recommend the shot for boys, such as the U.S., Brazil, Canada, Australia and others. HPV Action Campaign Director Peter Baker said in a [url=http://www.hpvaction.org/news" \t "_blank]statement[/url] that the decision means that we are no longer attempting to tackle the scourge of HPV with one hand tied behind our back.

In fact, it appears that there is no end to this vaccine’s alleged miracles, because in April 2018, The Daily Mail reported that a recent study had also linked HPV to prostate cancer. They stated that:

New research by scientists in Italy shows that having the human papilloma virus (HPV), which the jab targets, increases a man’s chances of a prostate tumour by nearly 40 percent.
It’s the second study in less than a year to link the virus, which was once thought to only trigger cervical cancer in women, with prostate tumours – a leading cause of death in British men.

Once again, Peter Baker, from HPV Action, had plenty to say on the subject. He stated that:

If the virus is linked to prostate cancer, that could be a game-changer.
It would make the case for vaccinating boys, which is already overwhelming, even more so.

Reading through the HPV Action website, it appears that the list of cancers that the HPV vaccine can supposedly protect you against just keeps on growing.
So, who exactly are HPV Action?
Health Impact News decided to take a closer look at this organization and we believe what we have discovered will shock many parents.

Health Impact News Uncovers the Truth

On the HPV Action website, they stated that:

ABOUT HPV ACTION

HPV Action (HPVA) is a collaborative partnership of 50 patient and professional organisations that are working to reduce the health burden of HPV. To achieve this, HPVA is delivering an advocacy campaign that aims to achieve gender-neutral HPV vaccination. This means that all boys and girls will be routinely offered vaccination against HPV at the age of 12/13.
HPVA believes that boys should now be included in the programme for the following reasons:
To ensure the maximum possible protection of women against cervical cancer.
To protect both men and women from other HPV-related cancers (anal, penile, head, neck, vaginal, vulval).
To protect both men and women from genital warts and also children and adults from recurrent respiratory papillomatosis (RRP).
We consider that it is unethical to exclude males from a vaccination programme that could significantly reduce their burden of cancer and protect their sexual health. [emphasis added]

HPV Action continued that:

HPVA receives no commercial sponsorship for its advocacy work. Its funding has come chiefly from its members and thanks are due to Throat Cancer Foundation, HPV and Anal Cancer Foundation, Oral Cancer Foundation (USA), Mouth Cancer Foundation, European Men’s Health Forum, Men’s Health Forum (GB), Men’s Health Forum in Ireland, Royal Society for Public Health, Terrence Higgins Trust, British Society for immunology, Cancer Focus Northern Ireland, London Friend, Society of Sexual Health Advisers, Oral Health Foundation, British Society of Dental Hygiene and Therapy, Children’s HIV Association of the UK & Ireland (CHIVA), Faculty of Sexual and Reproductive Healthcare and The School and Public Health Nurses Association. HPVA’s funds are administered by the Oral Health Foundation. [emphasis added]

We found this particular statement extremely interesting, because, according to our research, the Oral Health Foundation receives funding directly from Merck, the pharmaceutical company who manufactures the HPV vaccine, Gardasil.

Proof that HPV Action is Rubbing Shoulders with the UK Government and Big Pharma

During our research, we came across an article that was published on the pharma news website, PMLIVE, titled MSD supports Jabs for the Boys campaign. The article stated:

HPV Action has launched a human papillomavirus (HPV) awareness campaign backed by pharma firm Merck Sharp and Dohme (MSD).
The group, which comprises 48 organisations who work together to reduce the health burden of HPV, was presented an education grant by MSD for Jabs for the Boys.

It appears that their information is correct, because it has actually been confirmed at the end of the page, on the HPV Action Jabs for Boys website:

Jabs for the Boys is provided by the Oral Health Foundation for HPV Action, a partnership of almost 50 patient and professional organisations that are working to reduce the health burden of HPV.
The site’s development has been supported by an educational grant to OHF from MSD. [emphasis added]

If this was not worrying enough, according to our research, HPV Action has been working closely with the Joint Committee on Vaccination and Immunisation (JCVI), the committee that is responsible for advising the UK health departments on immunization.
Section 5 of the JCVI minutes dated October 4, 2017, stated that:

The Committee noted that PHE had met with HPV Action after the Subcommittee meeting to discuss its work and provide the stakeholder with the opportunity to ask questions. PHE had also indicated to the subcommittee that it would be willing to share more details on the methodology of the assessment on a pre-publication server once final reviews were completed. It was also noted that the University of Warwick work was close to being published and an earlier draft had been shared in confidence with HPV Action.
The stakeholders had also suggested the PHE estimates for the attributable fraction (AF) of HPV types causing oropharyngeal cancers were too low. PHE had outlined its data sources for this at the subcommittee meeting and subsequently also to HPV Action in a separate meeting. PHE agreed to present to JCVI a quick analysis of what proportion of the benefits from vaccination would be due to the prevention of oropharyngeal cancers and whether changing the AF would make a substantial difference to the overall conclusions. [emphasis added]

What is even more alarming is the fact that, according to the minutes, several members of the JCVI committee had admitted they had direct or indirect links to the pharmaceutical industry.
In fact, several members actually had links to Merck:

Professor Andrew Pollard (Chair)

Professor Pollard receives no personal payments from the manufacturers of vaccines.
A study funded by Okairos, initiated prior to his appointment to JCVI, was completed during 2016.
He is Director of the Oxford Vaccine Group in the Department of Paediatrics and has current research funding from the Bill and Melinda Gates Foundation, the National Institute for Health Research, the European Commission, Innovate UK, and the Global Alliance for Vaccines and Immunisation (GAVI). He chairs the scientific advisory group on vaccines for the European Medicines Agency and is a member of WHO’s SAGE.
Other investigators in the Department conduct research funded by vaccine manufacturers and the Department has received unrestricted educational grant funding for a three-day course from Gilead, MSD, GSK and Astra Zeneca.

Mrs. Anne McGowan

Mrs. McGowan receives no payments from the manufacturers of vaccines.
Mrs. McGowan’s employer Public Health Wales develop educational materials with funding from Pfizer, Sanofi Pasteur MSD, Novartis, Astra Zeneca and Wyeth.

Professor Maarten Postma

Professor Postma has received honoraria from SPMSD (health economics) MSD (health economics), and is an advisor to companies on Rotateq and Rotarix vaccines.
Professor Postma works for the University of Groningen which receives grants from SPMSD and GSK for work related to influenza vaccines.
Professor Postma attends advisory boards unrelated to vaccines or vaccine industry.
Professor Postma organized a conference which was financially supported by Pfizer relating to Health Economics.

Sadly, these are the people who are making decisions that affect our children’s health.

Growing Concerns Voiced by Parents with Daughters Injured by the HPV Vaccine

There has been documented evidence that the HPV vaccine has caused more injuries than any other vaccination in history. Despite this evidence, however, the HPV vaccination has continued to be hailed a success by the pharmaceutical industry and governments alike.
According to the MHRA, the adverse event reporting system in the UK, there have been a total of 9,119 reports of adverse reactions reported in the UK since the vaccine was launched in 2008. These reports equate to 23,882 different ailments and include a total of 8 deaths.

The UK’s decision to include boys into the equation has alarmed many parents whose daughters have already been injured by the vaccine. Amanda Dew, whose daughter was seriously injured after she received the vaccine in 2015, gave us the following statement:

It was no surprise when the UK health authorities announced recently that boys will soon be offered the HPV vaccine in England.
As parents who have seen our daughters’ health decline swiftly and chronically since they received their doses of the same vaccine years ago, we can only wait in dreaded anticipation of what’s to come.
The symptoms we have witnessed (broadly affecting the autonomic nervous system, plus chronic fatigue and persistent pain) are repeatedly denied as side effects by both the NHS and Public Health England.
Yet, there are no tests available to draw such a conclusion, and still we are meant to be reassured that the vaccine is safe.
We are not and neither should you be.
Many parents and (far too few) good scientists, members of the Executive and journalists have been fighting to raise awareness of the scandal that is the HPV vaccine.
If the flawed clinical trials, atrocious safety record and lack of proof of efficacy (cervical cancer rates have not fallen in young women in the UK, and Sweden has even reported an increase in cervical cancer rates that may possibly be due to the HPV vaccine)¹are not enough to question the programme, then what do we do next?

As an example of how one country tackled the large number of injuries that were believed to have been caused by the vaccine, Mrs. Dew explained that:

In Japan where the vaccine is no longer recommended, the girls affected have had blood serum analysed to reveal auto-antibodies; PET scans which show loss of blood to the brain, and cognitive tests which show that memory loss and brain fog, is real, and not just ‘all in their heads.’
In the UK, it seems to be a case of not looking for problems you don’t dare to find because the HPV vaccine programme must continue at any cost.
But we have had enough.
Scientists from the Nordic Cochrane Centre and Centre for Evidence Based Medicine have this week, issued a highly critical analysis of an HPV vaccine review².
Why is that important? Because PHE relied on the initial review to try to prove the vaccine is fine. Ultimately our children pay the price for poor reviews on top of poor safety checks.
No one is ‘policing the police.’
So, until time and courage reveal the truth, this is a plea to parents to conduct their own research on the safety and effectiveness of the HPV vaccine, because our public health system is utterly failing you.
Only then can you provide true informed consent. See www.timeforaction.org.uk for further information or search for ‘side effects of the HPV vaccine’ and you will see the unfolding of a global health crisis.

Mrs. Dew is not the only angry parent voicing their concerns in the UK.
The UK campaign group, Time for Action, is run by a group of UK parents whose daughters have all experienced serious health problems after receiving the HPV vaccination. They are all extremely angry about the UK’s decision.
In fact, they are so concerned that they have written the following statement on their website:

Time for Action are committed to ensuring that safety concerns associated with the HPV vaccines are thoroughly investigated and that adverse reactions are properly recognised, with timely and appropriate treatment options offered to patients who have been adversely affected by the vaccine.
The Time for Action group feel the concerns included in its submission to the JCVI last August remain, and that these concerns have not been addressed or properly investigated before this extension of the HPV vaccination programme to teenage boys.
The group will continue to ensure verified factual information and peer-reviewed scientific papers are made available to parents to help them make an informed decision on HPV vaccination.

We spoke to Time for Action and asked them if they would be prepared to write a statement for us. They stated that:

Time for Action acknowledge that there may be future benefits derived from the HPV vaccine but at the moment we believe there are also serious risks that are not being addressed.
The group is committed to ensuring that safety concerns associated with the HPV vaccines are thoroughly investigated and that adverse reactions are properly recognised, with timely and appropriate treatment options offered to patients who have been adversely affected by the vaccine.
The Time for Action group are disappointed with the recent government decision to extend the HPV vaccination programme to teenage boys, feeling the concerns raised in our submission to the JCVI last August remain, and that these concerns have not been addressed or properly investigated before this extension of the HPV vaccination programme has been agreed.
The group will continue to monitor reports of all adverse reactions and will support families of both girls and boys who develop health problems following HPV vaccination. Time for Action will continue to ensure verified factual information and peer-reviewed scientific papers are made available to parents to help them make an informed decision on HPV vaccination. The group can be contacted through the Time for Action website at [url=http://www.timeforaction.org.uk/" \t "_blank]www.timeforaction.org.uk[/url].

UK Government to Begin Giving HPV Vaccine to Boys Amid Public Outcry Image-2-1024x596

Data from Time for Action (2018)
We asked specialist in obstetrics and gynaecology, Dr. Christian Fiala, who had recently been featured in the HPV documentary series, Sacrificial Virgins, what action he would like governments to take regarding the HPV vaccine. He told us that:

An immediate moratorium until the efficacy of HPV vaccine for cervical cancer has been established and the possible cause of the vaccine for the reported side effects, some of them serious or even lethal has been determined.
What we know so far is that cervical cancer is‚ associated, that is, correlated to the presence of HPV. No causal link has been established so far. But a vaccine is fundamentally useless if the causal relationship has not been established without any doubt.
Strangely enough, this fundamental problem is widely ignored. Even among doctors and scientists. Although it is well known that the most frequent error in science is exactly that: mixing up correlation and causation.
There are many examples about correlations which are not based on causation. A Google search will give you some idea. One obvious example is the presence of storks and the number of children born. In eastern Austria, we have many storks (Burgenland) and I plotted the number of storks and deliveries together. As you can see there are times when there is a good correlation. However, no one would call to increase the stork population as a means to increase the birth rate.
The HPV vaccine and cervical cancer is exactly the same. We will get rid of HPV but this will have no impact on cervical cancer rates. It will only reduce the HPV-related cervical cancer but the overall rate of cervical cancer will be unchanged.
However, you need to keep in mind that the rate of cervical cancer has declined over the last decades in most countries (obviously without any vaccine). Consequently, one could expect this development to continue further.
In other words, a small decrease in the overall rate of cervical cancer over the next years will not necessarily be proof of an effect of the vaccine but rather the continuation of a development which we have observed over the last decades.

After publishing hundreds of articles on the HPV vaccine, Health Impact News believes that Dr. Fiala is absolutely correct.
We would like to thank Amanda Dew, Time for Action and Dr. Fiala for their contributions to this article.

More information about Gardasil

UK Government to Begin Giving HPV Vaccine to Boys Amid Public Outcry Gardasil_collage-3

Young women whose lives were destroyed by the HPV vaccine.

UK Government to Begin Giving HPV Vaccine to Boys Amid Public Outcry

1 UK Government to Begin Giving HPV Vaccine to Boys Amid Public Outcry Wed Aug 01, 2018 10:00 am

PurpleSkyz